Synbiotic therapy: A promising new adjunctive therapy for ulcerative colitis

Nutrition Reviews

Volumn 64, Issue 3, 2006, Pages 132-138

  Haskey, Natasha ^a   Dahl, Wendy J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Prebiotics; Probiotics; Synbiotic; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; BALSALAZIDE; CORTICOSTEROID; CYCLOSPORIN; FRUTAFIT; INSULIN; ISPAGULA; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREBIOTIC AGENT; PREDNISONE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; VSL 3 PROBIOTIC;

ANAMNESIS; BARLEY; BIFIDOBACTERIUM; BONE DENSITY; BONE MARROW SUPPRESSION; CANCER; CASE REPORT; CATARACT; CLINICAL FEATURE; CLINICAL TRIAL; COLON RESECTION; ENTERITIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GLAUCOMA; GROWTH DISORDER; HISTOLOGY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; MEDICAL LITERATURE; MICROFLORA; PATHOGENESIS; PROPHYLAXIS; QUALITY OF LIFE; REMISSION; REVIEW; SACCHAROMYCES BOULARDII; SCHOOL CHILD; SIDE EFFECT; SYNBIOTIC THERAPY; ULCERATIVE COLITIS; YEAST; INTESTINE; MICROBIOLOGY; TREATMENT OUTCOME;

BIFIDOBACTERIUM; HORDEUM VULGARE SUBSP. VULGARE; PLANTAGO OVATA; SACCHAROMYCES BOULARDII;

BIFIDOBACTERIUM; COLITIS, ULCERATIVE; HUMANS; INTESTINES; PROBIOTICS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33645729029     PISSN: 00296643     EISSN: 00296643     Source Type: Journal    
DOI: 10.1301/nr.2006.janr.132-138     Document Type: Review

References (32)

1. Friedman S, Blumberg R. Inflammatory bowel disease. In: Kasper D, Fauci A, Longo D, et al., eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005; 1776-1789.
2. Loftus E. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology. 2004;126:1504-1517.
3. Chudleigh V, Hunter J. Dietary therapy in IBD. IBD Mon. 2003;5:18-23.
4. Gremse D, Crissinger K. Ulcerative colitis in children: medical management. Pediatr Drugs. 2002;4:807-815.
5. Cummings J, Macfarlane G, Macfarlane S. Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol. 2003;4:9-20.
6. Steidler L. Microbiological and immunological strategies for treatment of inflammatory bowel disease. Microbes Infect. 2001;3:1157-1166.
7. Wylie R, Sarigol S. The treatment of inflammatory bowel disease in children. Clin Pediatr. 1998;38:421-426.
8. Bremner A, Griffiths D, Beattie R. Current therapy of ulcerative colitis in children. Expert Opin. Pharmacother. 2004;5:37-53.
9. Tomomasa T, Kobayashi A, Ushijima K, et al.; Working Group of the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guidelines for treatment of ulcerative colitis in children. Pediatr Int. 2004;46:494-496.
10. Hyams J, Davis P, Grancher K, Lerer T, Justinich C, Markowitz J. Clinical outcome of ulcerative colitis in children. J Pediatr. 1996;129:81-88.
11. Crohn's and Colitis Foundation of America. Info for Kids and Teens. Available online at: http://www.ccfa.org/kidsteens/?LMI=5. Accessed February 7, 2006.
12. Mahadevan U, Sandborn W. Diagnosis and management of pouchitis. Gastroenterology. 2003;124:1636-1650.
13. Gibson G, Roberfroid M. Dietary modulation of the human colonic microflora: introducing the concept of prebiotics. J Nutr. 1995;125:1401-1412.
14. Videla S, Vilaseca J, Antolin M, et al. Dietary inulin improves distal colitis induced by dextran sodium sulphate in the rat. Am J Gastroenterol. 2001;96:1486-1493.
15. Welters C, Heineman E, ThunnissenF, van den Bogaard A, Soeters P, Baeten C. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum. 2002;45:621-627.
16. Kanauchi O, Mitsuyama K, Homma T, et al. Treatment of ulcerative colitis by long term administration of germinated barley food stuff: multi-center open control trial. Int J Mol Med. 2003;12:701-704.
17. Hallert C, Kaldma M, Petersson B. Isaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. Scan J Gastroenterol. 1991;26:747-750.
18. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana L, et al. Randomized control trial of plantago ovato seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Am J Gastroenterol. 1999;94:427-433.
19. Schrezenmeir J, De Vrese M. Probiotics, prebiotics and synbiotics - approaching a definition. Am J Clin Nutr. 2001;73:S361-S364.
20. Tomasik PJ, Tomasik P. Probiotics and prebiotics. Cereal Chemistry. 2003;80:113-117.
21. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remisson of ulcerative colitis. Aliment Pharmacol Ther. 1997;11:853-858.
22. Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004;53:1617-1623.
23. Rembacken B, Snelling A, Hawkey P, Chalmers D, Axon A. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet. 1999;354:635-639.
24. Tursi A, Brandimarte G, Giorgetti G, Forti G, Modeo M, Gigliobianco A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to moderate ulcerative colitis. Med Sci Monit. 2004;10:126-131.
25. Venturi A, Gionchetti P, Rizzello F, et al. Impact on the composition of the fecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther. 1999;13:1103-1108.
26. Guslandi M, Giollo P, Testoni P. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol. 2003;15:697-698.
27. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr. 2003;22:56-63.
28. Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004;20:133-1141.
29. Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R. Experience of long-tern synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg. 2004;39:1686-1692.
30. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomized controlled trial. Gut. 2005;54:242-249.
31. Jowett S, Seal C, Roger B, Barton J, Welfare M. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important changes in ulcerative colitis. Am J Gastroenterol. 2001;96:2921-2928.
32. Tamboli C, Caucheteux C, Cortot A, Colombel J, Desreumaux P. Probiotics in inflammatory bowel disease: a critical review. Best Prac Res Clin Gastroenterol. 2003;17:805-820.